Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function.

Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function.
复制标题

DOI:
10.5588/ijtld.20.0906
复制
发表时间:
2021-04-01
期刊:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
影响因子:
--
通讯作者:
Mortimer K
Mortimer K
中科院分区:
其他
文献类型:
--
作者:
Allwood BW;Stolbrink M;Baines N;Louw E;Wademan DT;Lupton-Smith A;Nel S;Maree D;Mpagama S;Osman M;Marx FM;Hoddinott G;Lesosky M;Rylance J;Mortimer K

文献摘要

被引文献

相似文献

持续的呼吸道症状和肺功能缺陷在结核病患者后很常见。我们的目标是定义结核病后肺部疾病(PTLD)的负担,并在两个结核病高发社区评估症状和损害之间的关系。这是一项对南非开普敦1-5年前完成结核病治疗的成年人的横断面调查。通过问卷调查、肺活量测定和6分钟步行距离(6MWD)来评估结局指标与相关因素之间的关系。在145名受试者中(平均年龄42岁,范围18-75岁;55名女性[38%]),55名(38%)有气流阻塞,84名(58%)用力肺活量(FVC)低,平均6MWD为463m(范围240-723)。呼吸道症状常见:慢性咳嗽27例(19%),喘息61例(42%),呼吸困难(改良MRC呼吸困难评分3~4分36例,25%)。FVC、梗阻与6MWD相关性较差。只有低体重指数与多变量分析的结果一致。只有19名参与者(13%)被诊断为呼吸系统疾病,16名(11%)目前接受了吸入器。在这个“治愈”的人群中,有大量的症状负担和生理损害,但客观结果指标之间的相关性很差,这突显了我们对PTLD的理解存在缺陷。
Persistent respiratory symptoms and lung function deficits are common after patients with TB. We aimed to define the burden of post-TB lung disease (PTLD) and assess associations between symptoms and impairment in two high TB incidence communities. This was a cross-sectional survey of adults in Cape Town, South Africa who completed TB treatment 1–5 years previously. Questionnaires, spirometry and 6-minute walking distance (6MWD) were used to assess relationships between outcome measures and associated factors. Of the 145 participants recruited (mean age: 42 years, range: 18–75; 55 [38%] women), 55 (38%) had airflow obstruction and 84 (58%) had low forced vital capacity (FVC); the mean 6MWD was 463 m (range: 240–723). Respiratory symptoms were common: chronic cough (n = 27, 19%), wheeze (n = 61, 42%) and dyspnoea (modified MRC dyspnoea score 3 or 4: n = 36, 25%). There was poor correlation between FVC or obstruction and 6MWD. Only low body mass index showed consistent association with outcomes on multivariable analyses. Only 19 (13%) participants had a diagnosis of respiratory disease, and 16 (11%) currently received inhalers. There was substantial burden of symptoms and physiological impairment in this “cured” population, but poor correlation between objective outcome measures, highlighting deficits in our understanding of PTLD.